INDRAMEDCO has declared results for the period ended Mar 2021.
Quarterly Results
[s2If !current_user_can(access_s2member_level1)] Login below to read further [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]
- Sales for period ended Mar 2021 is Rs 198.0 cr compared to Rs 200.0 cr for period ended Mar 2020, a fall of 1.0%
- Operating Profits reported at Rs 30.0 cr for period ended Mar 2021 vis-vis 18.0 for period ended Mar 2020 .
- Operating Margins expanded 615.2 bps for period ended Mar 2021 vis-vis Mar 2020 .
- The EPS for Mar 2021 was Rs 1.65 compared to Rs 1.31 for previous quarter ended Dec 2020 and Rs 0.71 for Mar 2020
- The stock is trading at Rs 99 and a market cap of Rs 904 cr
[/s2If]
Price Chart
Further analysis and Full Company Research with investing scores is available here: INDRAMEDCO